| Serial Number | 88083193 |
| Word Mark | SYNTHORX |
| Filing Date | Friday, August 17, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 16, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 12, 2019 |
| Goods and Services | Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics |
| Goods and Services | Medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 27, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 27, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Synthorx, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Party Name | Synthorx, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Event Date | Event Description |
| Monday, May 16, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 16, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, August 25, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 24, 2021 | SOU EXTENSION 5 GRANTED |
| Thursday, August 19, 2021 | SOU EXTENSION 5 FILED |
| Tuesday, August 24, 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, August 19, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 16, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 12, 2021 | SOU EXTENSION 4 GRANTED |
| Friday, February 12, 2021 | SOU EXTENSION 4 FILED |
| Friday, February 12, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, September 11, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 9, 2020 | SOU EXTENSION 3 GRANTED |
| Wednesday, September 9, 2020 | SOU EXTENSION 3 FILED |
| Wednesday, September 9, 2020 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, April 1, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 30, 2020 | SOU EXTENSION 2 GRANTED |
| Monday, March 30, 2020 | SOU EXTENSION 2 FILED |
| Monday, March 30, 2020 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 10, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 10, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, February 7, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, February 7, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, October 1, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, September 27, 2019 | SOU EXTENSION 1 GRANTED |
| Friday, September 27, 2019 | SOU EXTENSION 1 FILED |
| Friday, September 27, 2019 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 9, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 12, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 12, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 23, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, January 7, 2019 | ASSIGNED TO LIE |
| Thursday, December 13, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 13, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, December 13, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 13, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 13, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, December 13, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 13, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, December 13, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 4, 2018 | ASSIGNED TO EXAMINER |
| Monday, August 27, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 21, 2018 | NEW APPLICATION ENTERED |